Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Other Accumulated Expenses (2022 - 2025)

Historic Other Accumulated Expenses for bioAffinity Technologies (BIAF) over the last 4 years, with Q3 2025 value amounting to $28658.0.

  • bioAffinity Technologies' Other Accumulated Expenses fell 3383.21% to $28658.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $28658.0, marking a year-over-year decrease of 3383.21%. This contributed to the annual value of $60035.0 for FY2024, which is 20790.34% up from last year.
  • bioAffinity Technologies' Other Accumulated Expenses amounted to $28658.0 in Q3 2025, which was down 3383.21% from $112590.0 recorded in Q2 2025.
  • bioAffinity Technologies' Other Accumulated Expenses' 5-year high stood at $112590.0 during Q2 2025, with a 5-year trough of $1751.0 in Q2 2024.
  • Its 4-year average for Other Accumulated Expenses is $29020.4, with a median of $16210.0 in 2023.
  • In the last 5 years, bioAffinity Technologies' Other Accumulated Expenses crashed by 6498.0% in 2024 and then surged by 633004.0% in 2025.
  • Over the past 4 years, bioAffinity Technologies' Other Accumulated Expenses (Quarter) stood at $5852.0 in 2022, then skyrocketed by 233.19% to $19498.0 in 2023, then soared by 207.9% to $60035.0 in 2024, then plummeted by 52.26% to $28658.0 in 2025.
  • Its Other Accumulated Expenses was $28658.0 in Q3 2025, compared to $112590.0 in Q2 2025 and $44205.0 in Q1 2025.